Company Name:Eli Lilly & Co.
CEO: David A. Ricks

Sector: Health Technology

Exchange: New York Stock Exchange

Country: US

Description: Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. Its products include Forteo, Adrica, BAQSIMI, Basaglar and Glucagn. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.


Key numbers

Market Capitalization:154800896500
Shares Outstanding: 957038000
Float: 844341990
Next Earning Date:2020-10-27
TTm EPS: 6.051
TTm Dividend Rate: 2.675
200 days moving average:139.61
50 days moving average: 158.14
One day percent Change: 1.7



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,